China Sky One Medical expects to have final SFDA approval for two more diagnostic kits by the end of 2009. One is a diagnostic test for Human Prostate Specific Antigen, an indicator of prostate related diseases, and the other is a determination kit for Luteinizing Hormone, a diagnosis test for female sterility. China Sky One plans to begin production of the two tests in 2010. They will join the company’s relatively new diagnostic testing division, which currently consists of three kits and contributed 6% of the company’s Q3 revenues. More details...
Stock Symbol: (NSDQ: CSKI)